Funds holding Disc Medicine Inc
ISIN US2546041011 · United States
- Fund holders
- 219
- Of which ETFs
- 44 175 other funds
- Value held
- ≈ 1.1B $ 1.1B $ · 30.2M SEK
- Share of capital
- 38.5 % of 38.4M shares on Jul 23, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 182 | 14K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 170 | 13.1K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 168 | 12.9K $ | 0.12 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 159 | 11.6K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 152 | 11.1K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 123 | 9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 116 | 8.5K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 100 | 7.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 80 | 5.9K $ | 0.10 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 76 | 5.6K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 70 | 5.1K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 42 | 3.1K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 32 | 2.3K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 26 | 1.8K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 24 | 1.8K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 24 | 1.7K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 10 | 770 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 8 | 585.1 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 8 | 556.6 $ | 0.05 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.69 % | as of May 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.62 % | as of Jun 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 1.25 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.18 % | as of May 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 0.99 % | as of May 29, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 0.89 % | as of Jul 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 0.77 % | as of Jun 30, 2026 ↗ |
| Lazard US Small Cap Equity Select Portfolio LAZARD FUNDS INC | 0.76 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.76 % | as of Jul 31, 2026 ↗ |
| Loomis Sayles Small Cap Growth Portfolio Brighthouse Funds Trust II | 0.68 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 217 | 0 | 14,744,768 | +2.4 % |
| 2026Q2 | 217 | -8 | 14,397,677 | +3.6 % |
| 2026Q1 | 225 | +24 | 13,896,627 | +20.5 % |
| 2025Q4 | 201 | +17 | 11,531,452 | +9.4 % |
| 2025Q3 | 184 | -11 | 10,542,206 | -1.0 % |
| 2025Q2 | 195 | +19 | 10,644,669 | +24.8 % |
| 2025Q1 | 176 | +15 | 8,532,143 | +51.8 % |
| 2024Q4 | 161 | +8 | 5,619,670 | +21.4 % |
| 2024Q3 | 153 | -7 | 4,629,189 | +9.0 % |
| 2024Q2 | 160 | +21 | 4,246,333 | +20.6 % |
| 2024Q1 | 139 | +18 | 3,520,688 | +24.4 % |
| 2023Q4 | 121 | 2,830,774 |
Institutional managers
196 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 5,586,894 | 357.2M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 2,450,221 | 156.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,273,831 | 145.4M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,735,376 | 111M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,698,244 | 108.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,549,350 | 99.1K $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 1,513,875 | 96.8M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,371,480 | 83.4M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 1,354,852 | 86.6M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 1,341,862 | 85.8M $ | as of Mar 31, 2026 |
| BVF INC/IL | 1,272,312 | 81.4M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 1,067,550 | 68.3M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 988,401 | 63.2M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 958,281 | 61.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 744,222 | 47.6M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 700,000 | 44.8M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 657,000 | 42M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 639,842 | 40.9M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 610,382 | 39M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 560,000 | 35.8M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 546,247 | 34.9M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 536,000 | 34.3M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 459,314 | 29.4M $ | as of Mar 31, 2026 |
| Saturn V Capital Management LP | 449,926 | 28.8M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 421,000 | 26.9M $ | as of Mar 31, 2026 |
Declared shareholders of Disc Medicine Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 12.80 % | 4,875,473 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Disc Medicine Inc". https://titelia.com/en/stocks/disc-medicine-inc-US2546041011